Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Reaffirms FY 2012 EPS Guidance; Issues FY 2013 Guidance Below Analysts' Estimates


Thursday, 3 Jan 2013 04:30pm EST 

Endo Health Solutions Inc announced that for fiscal 2012, it expects adjusted diluted earnings per share (EPS) in the range of $5.00 to $5.10 and GAAP diluted earnings per share in the range of $0.87-$0.97. For fiscal 2013, it expects total revenue between $2.80-$2.95 billion, adjusted diluted earnings per share between $4.40-$4.70 According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $5.00 for fiscal 2012; revenue of $3.05 billion and EPS of $5.08 for fiscal 2013. 

Company Quote

65.32
0.71 +1.10%
3:25pm EDT